Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- (-) Regulatory compliance (3)
- (-) Shortages (2)
- Alert/Advisory (12)
- Medicine safety (8)
- Prescription medicines (5)
- Safety (5)
- Australian Register of Therapeutic Goods (ARTG) (3)
- Listed medicines (3)
- Medical devices safety (3)
- Complementary medicines (2)
- Import and export (2)
- Advertising (1)
- Labelling and packaging (1)
- Non-prescription medicines (1)
- Over the counter (OTC) medicines (1)
- Therapeutic goods regulation (1)
- Weight loss products (1)
Search
4 result(s) found, displaying 1 to 4
-
Medicine shortage alertsRitalin and Artige immediate-release tablets are now also in shortage, and a shortage of Ritalin LA capsules is anticipated.
-
Safety alertsFurther examples of counterfeit Ozempic-labelled products have been detected and stopped at the Australian border.
-
Market actionsTakeda Pharmaceuticals Australia has issued a product alert for Vyvanse capsules due to minor packaging errors. The medication is safe to use as prescribed.
-
Safety alertsMagnum XXL capsules pose a serious risk to your health and should not be taken.